KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Gsk (GSK) over the last 17 years, with Q1 2025 value amounting to 0.02.

  • Gsk's Equity Ratio changed N/A to 0.02 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.02, marking a year-over-year change of. This contributed to the annual value of 0.22 for FY2024, which is 271.07% down from last year.
  • Gsk's Equity Ratio amounted to 0.02 in Q1 2025.
  • In the past 5 years, Gsk's Equity Ratio ranged from a high of 0.23 in Q4 2023 and a low of 0.02 during Q1 2021
  • Over the past 5 years, Gsk's median Equity Ratio value was 0.19 (recorded in 2021), while the average stood at 0.15.
  • Per our database at Business Quant, Gsk's Equity Ratio crashed by 741.74% in 2022 and then soared by 2837.42% in 2023.
  • Gsk's Equity Ratio (Quarter) stood at 0.19 in 2021, then fell by 7.42% to 0.18 in 2022, then rose by 28.37% to 0.23 in 2023, then fell by 2.71% to 0.22 in 2024, then crashed by 89.9% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q1 2025, 0.22 for Q4 2024, and 0.23 during Q4 2023.